Galectin Therapeutics Inc (GALT)
2.78
+0.06
(+2.21%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
-0.01
(-0.36%)
After-Hours: 20:00
Galectin Therapeutics Market Cap: 174.48M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 174.48M |
| November 21, 2024 | 170.71M |
| November 20, 2024 | 176.67M |
| November 19, 2024 | 172.91M |
| November 18, 2024 | 168.83M |
| November 15, 2024 | 173.85M |
| November 14, 2024 | 172.60M |
| November 13, 2024 | 182.01M |
| November 12, 2024 | 185.77M |
| November 11, 2024 | 181.38M |
| November 08, 2024 | 188.29M |
| November 07, 2024 | 176.96M |
| November 06, 2024 | 175.09M |
| November 05, 2024 | 162.31M |
| November 04, 2024 | 157.33M |
| November 01, 2024 | 155.77M |
| October 31, 2024 | 153.90M |
| October 30, 2024 | 157.02M |
| October 29, 2024 | 158.57M |
| October 28, 2024 | 155.15M |
| October 25, 2024 | 156.39M |
| October 24, 2024 | 158.89M |
| October 23, 2024 | 160.75M |
| October 22, 2024 | 163.25M |
| October 21, 2024 | 163.87M |
| Date | Value |
|---|---|
| October 18, 2024 | 166.36M |
| October 17, 2024 | 165.74M |
| October 16, 2024 | 163.87M |
| October 15, 2024 | 162.00M |
| October 14, 2024 | 163.87M |
| October 11, 2024 | 168.23M |
| October 10, 2024 | 160.75M |
| October 09, 2024 | 163.87M |
| October 08, 2024 | 170.72M |
| October 07, 2024 | 165.74M |
| October 04, 2024 | 175.71M |
| October 03, 2024 | 169.48M |
| October 02, 2024 | 169.48M |
| October 01, 2024 | 169.48M |
| September 30, 2024 | 171.35M |
| September 27, 2024 | 168.77M |
| September 26, 2024 | 165.04M |
| September 25, 2024 | 163.79M |
| September 24, 2024 | 166.28M |
| September 23, 2024 | 169.40M |
| September 20, 2024 | 172.51M |
| September 19, 2024 | 176.87M |
| September 18, 2024 | 168.77M |
| September 17, 2024 | 172.51M |
| September 16, 2024 | 169.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
61.21M
Minimum
Dec 28 2022
291.65M
Maximum
Apr 28 2021
136.67M
Average
129.51M
Median
Market Cap Benchmarks
| Microbot Medical Inc | 16.59M |
| Alaunos Therapeutics Inc | 3.827M |
| SELLAS Life Sciences Group Inc | 82.35M |
| Oragenics Inc | 3.346M |
| Anavex Life Sciences Corp | 772.49M |
Market Cap Related Metrics
| Price | 2.78 |
| Earnings Yield | -26.26% |